Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: West German Study Group
Condition: Carcinoma, Ductal, Breast
NCT01891357
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
Early termination due to significant lack of relevant patient data for evaluation of objectives.